206 related articles for article (PubMed ID: 11001839)
1. Bacterial genetics and human immunity to group B streptococci.
Adderson EE; Takahashi S; Bohnsack JF
Mol Genet Metab; 2000; 71(1-2):451-4. PubMed ID: 11001839
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a.
Bohnsack JF; Takahashi S; Hammitt L; Miller DV; Aly AA; Adderson EE
Infect Immun; 2000 Sep; 68(9):5018-25. PubMed ID: 10948119
[TBL] [Abstract][Full Text] [Related]
3. The effects of interferon-gamma and transforming growth factor-beta on adherence and survival of group B Streptococcus type III strains in ECV304 cells.
Santos GS; Miyazaki NH; Mattos-Guaraldi AL; Nagao PE
Int J Mol Med; 2003 Mar; 11(3):401-6. PubMed ID: 12579348
[TBL] [Abstract][Full Text] [Related]
4. Capsular sialic acid limits C5a production on type III group B streptococci.
Takahashi S; Aoyagi Y; Adderson EE; Okuwaki Y; Bohnsack JF
Infect Immun; 1999 Apr; 67(4):1866-70. PubMed ID: 10085029
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3.
Bohnsack JF; Takahashi S; Detrick SR; Pelinka LR; Hammitt LL; Aly AA; Whiting AA; Adderson EE
J Infect Dis; 2001 Jun; 183(11):1694-7. PubMed ID: 11343222
[TBL] [Abstract][Full Text] [Related]
6. Serotypes of 286 group B streptococci isolated from asymptomatic carriers and invasive disease cases in Mexico.
Palacios GC; González MN; Beltrán M; Arredondo JL; Torres J; Solórzano F
Rev Latinoam Microbiol; 2005; 47(1-2):21-4. PubMed ID: 17061543
[TBL] [Abstract][Full Text] [Related]
7. Genetic differences between invasive and noninvasive neonatal group B streptococcal isolates.
Fluegge K; Wons J; Spellerberg B; Swoboda S; Siedler A; Hufnagel M; Berner R
Pediatr Infect Dis J; 2011 Dec; 30(12):1027-31. PubMed ID: 21775921
[TBL] [Abstract][Full Text] [Related]
8. Opsonisation of group B streptococci and restriction endonuclease digestion patterns of their chromosomal DNA.
Takahashi S; Nagano Y; Nagano N; Fujita K; Taguchi F; Okuwaki Y
J Med Microbiol; 1993 Mar; 38(3):191-6. PubMed ID: 8455188
[TBL] [Abstract][Full Text] [Related]
9. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci.
Takahashi S; Adderson EE; Nagano Y; Nagano N; Briesacher MR; Bohnsack JF
J Infect Dis; 1998 Apr; 177(4):1116-9. PubMed ID: 9534996
[TBL] [Abstract][Full Text] [Related]
10. Correlation of phylogenetic lineages of group B Streptococci, identified by analysis of restriction-digestion patterns of genomic DNA, with infB alleles and mobile genetic elements.
Takahashi S; Detrick S; Whiting AA; Blaschke-Bonkowksy AJ; Aoyagi Y; Adderson EE; Bohnsack JF
J Infect Dis; 2002 Oct; 186(7):1034-8. PubMed ID: 12232847
[TBL] [Abstract][Full Text] [Related]
11. Intracellular viability in human non-polarized respiratory epithelial 16 HBE 14o- cells by group B Streptococcus serotype III clinical isolates presenting 162-kb and 183-kb virulence markers.
Sá de São José A; Miyazaki NH; Hirata R; Mattos-Guaraldi AL; Nagao PE
Int J Mol Med; 2006 Mar; 17(3):533-8. PubMed ID: 16465404
[TBL] [Abstract][Full Text] [Related]
12. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of serotype III group B-streptococcus isolates causing neonatal meningitis.
Bidet P; Brahimi N; Chalas C; Aujard Y; Bingen E
J Infect Dis; 2003 Oct; 188(8):1132-7. PubMed ID: 14551882
[TBL] [Abstract][Full Text] [Related]
15. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae.
Seifert KN; Adderson EE; Whiting AA; Bohnsack JF; Crowley PJ; Brady LJ
Microbiology (Reading); 2006 Apr; 152(Pt 4):1029-1040. PubMed ID: 16549667
[TBL] [Abstract][Full Text] [Related]
16. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae.
Adderson EE; Takahashi S; Wang Y; Armstrong J; Miller DV; Bohnsack JF
Infect Immun; 2003 Dec; 71(12):6857-63. PubMed ID: 14638773
[TBL] [Abstract][Full Text] [Related]
17. Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS).
Fleming KE; Bohnsack JF; Palacios GC; Takahashi S; Adderson EE
J Med Microbiol; 2004 Jun; 53(Pt 6):505-508. PubMed ID: 15150329
[TBL] [Abstract][Full Text] [Related]
18. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups.
Zhao Z; Kong F; Zeng X; Gidding HF; Morgan J; Gilbert GL
Clin Microbiol Infect; 2008 Mar; 14(3):260-7. PubMed ID: 18190584
[TBL] [Abstract][Full Text] [Related]
19. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing.
Takahashi S; Nagano Y; Nagano N; Hayashi O; Taguchi F; Okuwaki Y
Infect Immun; 1995 Dec; 63(12):4764-9. PubMed ID: 7591133
[TBL] [Abstract][Full Text] [Related]
20. Restriction endonuclease digest patterns of chromosomal DNA from group B beta-haemolytic streptococci.
Nagano Y; Nagano N; Takahashi S; Murono K; Fujita K; Taguchi F; Okuwaki Y
J Med Microbiol; 1991 Nov; 35(5):297-303. PubMed ID: 1658325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
